Related Experiment Video
Updated: Dec 17, 2025
12:52
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
16.3K
GLI2-Mediated Inflammation in the Tumor Microenvironment
Weiguo Han1, Shereen A Allam1, Sherine F Elsawa2
1Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH, USA.
Advances in Experimental Medicine and Biology
|June 27, 2020
Summary
The transcription factor GLI2 regulates inflammation in the tumor microenvironment (TME) through both Hedgehog (HH) dependent and independent pathways. GLI2 modulates cytokine genes, impacting cancer progression and therapy resistance.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The tumor microenvironment (TME) is critical in cancer development, progression, and therapeutic resistance.
- Inflammation is a key feature of cancer, influencing its phenotype and progression.
- Understanding inflammation regulation in cancer is vital for cancer cell biology insights.
Purpose of the Study:
- To explore the role of the transcription factor GLI2 in regulating inflammation within the TME.
- To elucidate GLI2's function independent of the Hedgehog (HH) signaling pathway.
- To identify downstream cytokine targets regulated by GLI2.
Main Methods:
- Review of canonical and noncanonical pathways governing GLI2 regulation.
- Analysis of GLI2's modulation of cytokine gene expression in the TME.
Main Results:
- GLI2 exhibits a role in mediating inflammation within the TME.
- GLI2's inflammatory function is, in part, independent of HH signaling.
- GLI2 directly influences the expression of several key cytokine genes.
Conclusions:
- GLI2 acts as a novel inflammatory mediator in cancer.
- Noncanonical GLI2 regulation offers new therapeutic targets for managing TME-driven inflammation.
- Further research into GLI2-cytokine interactions can advance cancer treatment strategies.
More Related Videos
Related Concept Videos
02:17The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
01:15Activation of Integrins
4.7K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
4.7K
01:27Tumor Immunotherapy
1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
01:17Intracellular Signaling Affects Focal Adhesions
3.4K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.4K
02:07Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
6.9K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
6.9K